Anticorps Recombinant de lapin anti-Phospho-IkB Beta (Thr19/Ser23)
Phospho-IkB Beta (Thr19/Ser23) Recombinant Antibody for WB, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (1)
Applications
WB, FC (Intra), ELISA
Conjugaison
Non conjugué
CloneNo.
241061B2
N° de cat : 84403-1-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | TNF alpha and Calyculin A treated HT-29 cells, |
| Résultats positifs en FC (Intra) | TNF alpha and Calyculin A treated HT-29 cells, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 1 publications below |
Informations sur le produit
84403-1-RR cible Phospho-IkB Beta (Thr19/Ser23) dans les applications de WB, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Réactivité citée | rat |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Peptide |
| Nom complet | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
| Masse moléculaire calculée | 356 aa, 38 kDa |
| Poids moléculaire observé | 50 kDa |
| Numéro d’acquisition GenBank | BC015528 |
| Symbole du gène | IkB Beta |
| Identification du gène (NCBI) | 4793 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
IkB Beta is also named as NF-kappa-B inhibitor beta (NFKBIB) and TRIP-9. IKBB is one of the major isoforms of the NFKB inhibitor which preferentially interacts with c-Rel or p65 NF-kB dimers (PMID: 26227166). IKBB was reported to be associated with tumor growth inhibition and metastasis in lung cancer (PMID: 11402320). IKBB also inhibits cancer cell regulation through inactivation of the NFkB pathway (PMID: 18950638). Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IkB, which frees NF-kB to translocate to the nucleus where it regulates gene transcription (PMID: 10837071). The antibody is phosphorylated at Thr19 and Ser23.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for Phospho-IkB Beta (Thr19/Ser23) antibody 84403-1-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |

